Abstract:Background Chronic hepatitis B is a primary cause of liver-related death. Interferon alpha (IFN-α) is able to inhibit the replication of hepadnavirus, and the sustained and stable expression of IFN-α at appropriate level may be beneficial to HBV clearance. With the development of molecular cloning technology, gene therapy plays a more and more important role in clinical practice. In light of the findings, an attempt to investigate the anti-HBV effects mediated by a eukaryotic expression plasmid (pSecTagB-IFN-α) in vitro was carried out. Methods HBV positive cell line HepG2.2.15 and its parental cell HepG2 were transfected with pSecTagB-IFN-α or empty plasmid by using Lipofectamine™ 2000 reagent. The expression levels of IFN-α were determined by reverse transcriptase polymerase chain reaction (RT-PCR) and ELISA methods. The effects of pSecTagB-IFN-α on HBV mRNA, DNA and antigens were analyzed by real-time fluorescence quantitative PCR (qRT-PCR) and ELISA assays. RT-PCR, qRT-PCR and western blot were employed to investigate the influence of pSecTagB-IFN-α on IFN-α-induced signal pathway. Furthermore, through qRT-PCR and ELISA assays, the suppressive effects of endogenously expressed IFN-α and the combination with lamivudine on HBV were also examined. Results pSecTagB-IFN-α could express efficiently in hepatoma cells, and then inhibited HBV replication, characterized by the decrease of HBV S gene (HBs) and HBV C gene (HBc) mRNA, the reduction of HBV DNA load, and the low contents of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg). Mechanism research showed that the activation of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signal pathway, the up-regulation of IFN-α-induced antiviral effectors and double-stranded (ds) RNA sensing receptors by delivering pSecTagB-IFN-α, could be responsible for these phenomena. Furthermore, pSecTagB-IFN-α vector revealed effectively anti-HBV effect than exogenously added IFN-α. Moreover, lamivudine combined with endogenously expressed IFN-α exhibited stronger anti-HBV effect than with exogenous IFN-α. Conclusion Our results showed that endogenously expressed IFN-α can effectively and persistently inhibit HBV replication in HBV infected cells. These observations opened a promising way to design new antiviral genetic engineering drugs based on IFN-α.

Baicalin Benefits the Anti-Hbv Therapy Via Inhibiting Hbv Viral Rnas

Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4α-HNF1α axis.

Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo

Sequential activation of ERα-AMPKα signaling by the flavonoid baicalin down-regulates viral HNF-dependent HBV replication

Tannic Acid Suppresses HBV Replication Via the Regulation of NF-κB, MAPKs, and Autophagy in HepG2.2.15 Cells.

Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon Α.

A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin

Baicalin combined with interferonαfor treating liber fibrosis in patients with chronic hepatitis B

Inhibition Mechanisms of Baicalin and Its Phospholipid Complex Against DHAV-1 Replication.

Anti-NDV activity of baicalin from a traditional Chinese medicine in vitro

Efficacy analysis of anti-viral treatment in patients with chronic hepatitis B

The Anti-Hbv Effect Mediated by a Novel Recombinant Eukaryotic Expression Vector for IFN-α

Beneficial Effects of Bushen Formula Combined with Enticavir on Chronic Hepatitis B Patients with Suboptimal Response to Enticavir by Regulating B-Cell Differentiation

Assessment of the Effect of Baicalin on Duck Virus Hepatitis

Role of Intrahepatic HBV DNA in Antivirus Therapy

Progress in Nucleoside and Nucleotide Analogue Therapy for Chronic Hepatitis B

Comprehensive Analysis of Hospital-Based Prospective Cohort Reveals the Unique Effectiveness and Safety for Nucleos(t)ide Analogues in HBV Patients.

Synthesis of baicalin carboxylate derivatives and their structure-Activity relationship analysis of their inhibitory activity on BVDV NS5B polymerase

In vitro Broad Antiviral Function against HBV, HSV, H3N2 Replication byBaicalin and Oroxylin A-7-O-ÃÂ-D-Glucoside

Baicalin, an inhibitor of HIV-1 production in vitro

Inhibition of hepatitis B virus through PPAR-JAK/STAT pathway modulation by electroacupuncture and tenofovir disoproxil fumarate combination therapy